The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings was published originally in September 2004 in which NIOSH identified a sample list of major hazardous drugs. The list was updated in 2010, 2012, 2014 and most recently in September 2016. The 2016 list added 34 hazardous drugs that pose a risk to healthcare workers who prepare and administer them to patients with cancer and other conditions; bringing the total to well over 100 hazardous drugs.
In April 2017, two changes were recommended to the list: NIOSH determined that telavancin (VIBATIV®) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH; in addition, the manufacturer of trabectedin (YONDELIS®) recommends that it be handled as a hazardous drug and therefore, NIOSH considers this drug to be included in Table 1 of the NIOSH list of hazardous drugs.
As of July 17, 2017 the PharmEcology® Waste Wizard® database has been updated to reflect these changes. If you recently received an Inventory Analysis, and your inventory includes either or both of these products, please adjust the preparation and handling of these products in your organization as described above.
Please email us at email@example.com or give us a call at 877-247-7430 if you have any questions or concerns.